Join us at the Life Sciences Forum at TCS Pace Port™, New York
Generative AI (GenAI) technologies have tremendous potential across the life sciences value chain. These technologies can improve health outcomes and quality of life—from accelerated drug discovery and faster, efficient clinical trials to autonomous manufacturing and improved sales and marketing.
The recently published TCS AI for Business Study brings forth the following interesting insights:
- 44% of the life sciences companies agreed to use AI to create new revenue streams
- 51% of executives want to build enterprise-specific large language models (LLMs) for GenAI implementations
- 58% of industry leaders favor an enterprise strategy for AI and want to experiment and take risks with AI
The potential of GenAI for the life sciences industry is promising. We invite you to discuss the vast potential of GenAI and challenges posed by regulated industries such as life sciences and technology and skill limitations that impede scale, and the collective way forward.
Join our keynote speaker and an eminent industry expert at the life sciences forum to discover how practitioners can adopt an AI-first mindset to build a next-gen enterprise. Gain insights on how to:
- Reimagine knowledge work and skills with AI augmentation to push the frontiers of enterprise performance
- Build an elite-by-design enterprise with a focus on high quality, consistency, and productivity
- Develop a secure, reliable, and resilient AI fabric with Responsible AI 2.0
Keynote speaker
- Sankaranarayanan Viswanathan, Vice President and Head of Business Innovation, Chief Technology Office, TCS
